New CDC population data from 2023 show that in 23 states more than one in three adults (35%) has obesity. Before 2013, no state had an adult obesity prevalence at or above 35%. Currently, at least one ...

As of 2020, the United States’ obesity epidemic impacts over 40% of the adult population. Although the CDC recognized this highly prevalent and serious ...

This summary covers several health-related news, including Germany's bird flu outbreak, Bristol Myers' lawsuit victory, ...

The injectable tracer, Flyrcado, could help doctors flag deadly coronary artery disease in patients during imaging tests.

Demand forweight-loss drugs has grown at an astonishing rate in recent years, driving share prices of healthcare giants such ...

The disparity in life expectancy and health quality between urban and rural men approaching retirement has grown over the ...

Roche argued that its obesity medications would prove to have advantages over its rivals’ — and that the demand for weight ...

Discover the revival of the biotech sector, with IPOs resurging and promising weight loss drug potential, despite facing ...

We recently published a list of 10 Best Major Stocks to Invest In According to Analysts. In this article, we are going to ...

The Swiss pharma is paying Regor Therapeutics $850 million to buy a pair of prospects it sees as potential successors to blockbuster medicines from Pfizer and Eli Lilly.

Duke-NUS scientists and their collaborators have discovered a potential new treatment for heart failure with preserved ...

Roche told investors on Monday that it plans to make significant cuts to both the cost and time it takes for it to develop ...